Search results
3 hours ago · Jul 16, 2024, 8:32 PM PDT. A new report from The New York Times describes the president's inner circle as shrinking. Kevin Dietsch/Getty Images. Recent polls show Trump leading Biden after Biden's ...
- 25 of the richest donors funneling money to Donald Trump ...
Business Insider USA Robert and Rebekah Mercer Robert...
- 25 of the richest donors funneling money to Donald Trump ...
7 hours ago · New research aiming to quantify brand ‘magnetism’ argues that too much market research still rests on outdated science and a flawed image what brands really are.
1 day ago · Business Insider USA Robert and Rebekah Mercer Robert Mercer, a former hedge fund CEO, has given $814,399 to the Trump 47 Committee.Both Robert and his daughter Rebekah have been major contributors to pro-Trump and more anti-establishment conservative causes, including helping to fund the right-wing Breitbart website and the conservative social media app Parler.
7 hours ago · Wed, Jul 17, 2024, 12:00 AM 4 min read. (Bloomberg) -- At least once a month — and sometimes as often as three times a week — a private plane lands in a secure part of Robert Gabriel Mugabe ...
7 hours ago · The 2024 United States presidential debates are a series of debates between major candidates of the 2024 United States presidential election. The first general election debate, sponsored by CNN, was attended by presumptive nominees Joe Biden and Donald Trump and was held on June 27, 2024. The second debate, which will be sponsored by ABC, is ...
5 hours ago · (CNN) — The Alameda County District Attorney’s office on Tuesday announced the resentencing of two death row inmates amid an ongoing ordered review of dozens of death penalty cases to determine whether prosecutors in those cases intentionally excluded Black and Jewish jurors. Ernest Dykes, the ...
7 hours ago · SOUTH SAN FRANCISCO, Calif., July 17, 2024--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline results from two arms of an ongoing multi-part Phase I clinical trial for CT-996, an investigational, once-daily, oral small molecule GLP-1 receptor agonist being developed for the treatment of both type 2 diabetes and obesity. 1 The ...
